《大行報告》大和上調百勝中國(09987.HK)目標價至603元 評級「買入」
大和發表研究報告指,日前參與了百勝中國(09987.HK)投資者日活動,管理層宣布啟動RGM2.0戰略,計劃在未來三年加快門店擴張步伐。
該行認為,百勝中國在中國餐飲服務行業中,以獨特的價值主張來把握消費情緒變化,盈利具良好可見性,股東背景亦為業務發展帶來支持,料將迎來潛在的估值重估,重申「買入」評級,並將今年第三季業績視為近期催化劑。
考慮到更樂觀的門店擴張計劃及股份回購的影響,大和將百勝2023至2025年每股盈利預測上調1%至3%,並將目標價由593.5元上調至603元,相信百勝的數字化生態系統及執行能力屬行業領先,有助於應對近期任何不確定性因素。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.